From Stock Story: 2025-05-06 18:05:00

Clover Health (NASDAQ:CLOV) reported Q1 CY2025 revenue of $462.3 million, a 33.3% increase year-on-year, but missed analyst estimates. GAAP EPS was $0, beating estimates of -$0.04. Adjusted EBITDA was $25.78 million, exceeding estimates of $9.27 million. The company’s operating margin improved to -0.3%. CEO Andrew Toy expressed satisfaction with membership growth and profitability expansion. Clover Health, founded in 2014, focuses on Medicare Advantage plans for seniors. Sales grew at a 23.8% compounded annual rate over the last five years, outperforming the industry average. The company aims to improve healthcare for seniors through technology.



Read more at Stock Story: Clover Health (NASDAQ:CLOV) Misses Q1 Sales Targets